JNJ ▲ +1.0% - Johnson & Johnson
$JNJ Johnson & Johnson Reports First Real-World VARIPULSE Pro Platform Data and 12-Month OMNYPULSE Platform Outcomes for Atrial Fibrillation Treatment at APHRS 2026
22-OCT-2026 07:47 AM ET
Share this post
More filings for $JNJ
JNJ ▼ -0.7% - Johnson & JohnsonOct 21, 2026JNJ ▲ +0.8% - Johnson & JohnsonOct 20, 2026JNJ ▼ -0.8% - Johnson & JohnsonOct 19, 2026JNJ ▼ -0.7% - Johnson & JohnsonOct 13, 2026JNJ ▲ +0.9% - Johnson & JohnsonOct 12, 2026JNJ ▲ +0.9% - Johnson & JohnsonOct 12, 2026
View full $JNJ filing history →💬 Comments
Loading comments…
Leave a comment